(Reuters) - SHANGHAI, April 19 - Hisun Group, a Chinese pharmaceutical maker, plans to sell a minority stake in its listed unit to foreign investors as it wants capital to boost its production, two sources close to the situation said on Thursday.
Hisun Group, headquartered in the eastern Chinese province of Zhejiang, has hired investment bank UBS to help it sell a stake in Zhejiang Hisun Pharmaceutical Co Ltd. , the sources said.
Read more at Reuters.com Mergers News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment